Wall Street has been moving into healthcare for several years and it has been making its mark in the fertility field. Some practices have taken advantage of the influx of money in the field, but several haven’t. But several docs have some concerns, specifically when it comes to decision making.

Do private equity firms or people who invest in fertility clinics and businesses really have the best patient care in mind?

On this episode of Inside Reproductive Health, Griffin talks to Dr. Francisco Arredondo, founder of RMA of Texas and author of his upcoming book, MedikalPreneur. Together, we dive into the pros and cons of money entering our field in the form of private equity.

Learn more about Dr. Arredondo here.

Mentioned in this episode:

Episode 74 - Dr. Francisco Arredondo

Harvard Business Review Article

Bloomberg Businessweek Article

To get started on a marketing plan for your company, complete the Goal and Competitive Diagnostic at FertilityBridge.com.